Dequalinium induces a selective depletion of mitochondrial DNA from HeLa human cervical carcinoma cells

Experimental Cell Research

Volumn 245, Issue 1, 1998, Pages 137-145

  Schneider Berlin, Kristen R ^a   Ammini, Chandramohan V ^a   Rowe, Thomas C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Dequalinium; DNA; Mitochondria

Indexed keywords

DEQUALINIUM; MITOCHONDRIAL DNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG EFFECT; DRUG SCREENING; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

EID: 0031797892     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4236     Document Type: Article

References (36)

1. Weiss, M. J., Wong, J. R., Ha, C. S., Bleday, R., Salem, R. R., Steele, G. D., Jr., and Chen, L. B. (1987). Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. Proc. Natl. Acad. Sci. USA 84, 5444-5448.
2. Chen, L. B. (1988). Mitochondrial membrane potential in living cells. Annu. Rev. Cell Biol. 4, 155-181.
3. Summerhayes, I. C., Lampidis, T. J., Bernal, S. D., Nadakavukaren, J. J., Nadakavukaren, K. K., Shepherd, E. L., and Chen, L. B. (1982). Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc. Natl. Acad. Sci. USA 79, 5292-5296.
4. Koya, K., Li, Y., Wang, H., Ukai, T., Tatsuta, N., Kawakami, M., Shishido, T., and Chen, L. B. (1996). MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. Cancer Res. 56, 538-543.
5. Bodden, W. L., Palayoor, S. T., and Hait, W. N. (1986). Selective antimitochondrial agents inhibit calmodulin. Biochem. Biophys. Res. Commun. 135, 574-582.
6. Bullough, D. A., Ceccarelli, E. A., Roise, D., and Allison, W. S. (1989). Inhibition of the bovine-heart mitochondrial F1-ATPase by cationic dyes and amphipathic peptides. Biochim. Biophys. Acta 975, 377-383.
7. Zhuo, S., and Allison, W. S. (1988). Inhibition and photoinactivation of the bovine heart mitochondrial F1-ATPase by the cytotoxic agent, dequalinium. Biochem. Biophys. Res. Commun. 152, 968-972.
8. Rotenberg, S. A., Smiley, S., Ueffing, M., Krauss, R. S., Chen, L. B., and Weinstein, I. B. (1990). Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium. Cancer Res. 50, 677-685.
9. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) "Molecular Cloning: A Laboratory Manual," Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
10. Labarca, C., and Paigen, K. (1980). A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102, 344-352.
11. Kroll, D. J., Borgert, C. J., Wiedmann, T.-W., and Rowe, T. C. (1990). Drug sensitivity of heat-resistant mouse B16 melanoma variants. Radiat. Res. 124, 15-21.
12. Lawrence, J. W., Claire, D. C., Weissig, V., and Rowe, T. C. (1996). Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells. Mol. Pharmacol. 50, 1178-1188.
13. Lawrence, J. W., Darkin Rattray, S., Xie, F., Neims, A. H., and Rowe, T. C. (1993). 4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells. J. Cell Biochem. 51, 165-174.
14. Segal Bendirdjian, E., Coulaud, D., Roques, B. P., and Le Pecq, J. B. (1988). Selective loss of mitochondrial DNA after treatment of cells with ditercalinium (NSC 335153), an antitumor bis-intercalating agent. Cancer Res. 48, 4982-4992.
15. Darzynkiewicz, Z., Traganos, F., Staiano Coico, L., Kapuscinski, J., and Melamed, M. R. (1982). Interaction of rhodamine 123 with living cells studied by flow cytometry. Cancer Res. 42, 799-806.
16. Wiseman, A., and Attardi, G. (1978). Reversible tenfold reduction in mitochondria DNA content of human cells treated with ethidium bromide. Mol. Gen. Genet. 167, 51-63.
17. Desjardins, P., Frost, E., and Morais, R. (1985). Ethidium bromide-induced loss of mitochondrial DNA from primary chicken embryo fibroblasts. Mol. Cell. Biol. 5, 1163-1169.
18. Tzagoloff, A. (1982) "Mitochondria," Plenum, New York.
19. Attardi, G., and Schatz, G. (1988). Biogenesis of mitochondria. Annu. Rev. Cell. Biol. 4, 289-333.
20. Desjardins, P., de Muys, J. M., and Morais, R. (1986). An established avian fibroblast cell line without mitochondrial DNA. Somat. Cell. Mol. Genet. 12, 133-139.
21. King, M. P., and Attardi, G. (1989). Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation. Science 246, 500-503.
22. Clayton, D. A. (1991). Replication and transcription of vertebrate mitochondrial DNA. Annu. Rev. Cell. Biol. 7, 453-478.
23. Nass, M. K. (1984). Analysis of methylglyoxal bis(guanylhydrazone)-induced alterations of hamster tumor mitochondria by correlated studies of selective rhodamine binding, ultrastructural damage, DNA replication, and reversibility. Cancer Res. 48, 4982-4992.
24. Vertino, P. M., Beerman, T. A., Kelly, E. J., Bergeron, R. J., and Porter, C. W. (1991). Selective cellular depletion of mitochondrial DNA by the polyamine analog N1,N12-bis(ethyl)spermine and its relationship to polyamine structure and function. Mol. Pharmacol. 39, 487-494.
25. Chen, C.-H., and Cheng, Y.-C. (1989). Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine. J. Biol. Chem. 264, 11934-11937.
26. Chen, L. B. (1989). Fluorescent labeling of mitochondria. Methods Cell Biol. 29, 103-123.
27. Wright, R. G., Wakelin, L. P., Fieldes, A., Acheson, R. M., and Waring, M. J. (1980). Effects of ring substituents and linker chains on the bifunctional intercalation of diacridines into deoxyribonucleic acid. Biochemistry 19, 5825-5836.
28. Shen, L. L. (1994). Molecular mechanisms of DNA gyrase inhibition by quinolone antibacterials. Adv. Pharmacol. 29A, 285-304.
29. Davis, T. N. (1992). A temperature-sensitive calmodulin mutant loses viability during mitosis. J. Cell Biol. 118, 607-617.
30. Davis, T. N., Urdea, M. S., Masiarz, F. R., and Thorner, J. (1986). Isolation of the yeast calmodulin gene: calmodulin is an essential protein. Cell 47, 423-431.
31. Sun, G. H., Hirata, A., Ohya, Y., and Anraku, Y. (1992). Mutations in yeast calmodulin cause defects in spindle pole body functions and nuclear integrity. J. Cell Biol. 119, 1625-1639.
32. Glass-Marmor, L., Morgenstern, H., and Beitner, R. (1996). Calmodulin antagonists decrease glucose 1,6-bisphosphate, fructose 1,6-bisphosphate, ATP and viability of melanoma cells. Eur. J. Pharmacol. 313, 265-271.
33. Kovac, L., Hrusovska, E., and Smigan, P. (1970). Oxidative phosphorylation in yeast: Inhibition of oxidative phosphorylation and of respiratory enzyme synthesis by oligomycin in intact cells. Biochim. Biophys. Acta 205, 520-523.
34. Schneider, K. R. (1997). Ph.D. dissertation, University of Florida.
35. Sun, X., Wong, J. R., Song, K., Hu, J., Garlid, K. D., and Chen, L. B. (1994). AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity. Cancer Res. 54, 1465-1471.
36. Modica-Napolitano, J. S., Koya, K., Weisberg, E., Brunelli, B. T., Li, Y., and Chen, L. B. (1996). Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. Cancer Res. 56, 544-550.